Abbott Laboratories (ABT) stock has had negative returns for the last 3 years. But don’t get fooled by that when analyzing ...

Abbott Laboratories, a healthcare giant with diverse divisions, is normalizing post-pandemic as its medical devices drive ...

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

A new device from Abbott Laboratories, called Lingo, is geared toward people who don’t have diabetes but want to see how food ...

Abbott Laboratories is a diversified healthcare company with strong segments, particularly Medical Devices. Read why I assign ...

Medical device giant Abbott Laboratories is launching a $7 billion stock buyback program. The repurchase of common shares was ...

Abbott Laboratories reported Q3 sales of $10.64 billion, driven by 8.2% organic growth in medical devices. Adjusted EPS for ...

Abbott Laboratories had a solid Q3, reporting 4.9% growth to outpace the consensus forecast despite the impact of lower COVID ...

On October 18, 2024, Abbott Laboratories Employees Credit Union (“ALEC”) filed a notice of data breach with the Attorney ...

Is the company still worth a look if you're a long-term investor? Abbott Laboratories is one of the world's leading medical device makers. It routinely develops and markets newer products ...

Abbott’s adjusted diluted earnings per share was $1.21, beating the analyst estimates of $1.20. Also Read: Abbott ...

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, ...